For citations:
TEMIRBULATOV I.I., KRYUKOV A.V., MIRZAEV K.B., DENISENKO N.P., ABDULLAEV S.P., ZHIRYAKOVA A.S., SHEVCHUK Y.V., VECHORKO V.I., AVERKOV O.V., SYCHEV D.A. The Effect of Carriage of CYP3A5*3 and CYP3A4*22 Polymorphic Variants on the Safety of Remdesivir Therapy in Patients with COVID-19. Antibiot Khimioter = Antibiotics and Chemotherapy. 2022;67(7-8):45-50. (In Russ.) https://doi.org/10.37489/0235-2990-2022-67-7-8-45-50
Email this article 